Michiko Yoshii

549 total citations
34 papers, 456 citations indexed

About

Michiko Yoshii is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Michiko Yoshii has authored 34 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Michiko Yoshii's work include Drug Transport and Resistance Mechanisms (19 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers) and Cholesterol and Lipid Metabolism (5 papers). Michiko Yoshii is often cited by papers focused on Drug Transport and Resistance Mechanisms (19 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers) and Cholesterol and Lipid Metabolism (5 papers). Michiko Yoshii collaborates with scholars based in Japan, United States and France. Michiko Yoshii's co-authors include Toru Hosoi, Koichiro Ozawa, Takahiko Hoshita, Kenji Kihira, Erwin H. Mosbach, Mizuho Une, Bertram I. Cohen, Charles K. McSherry, Masaki Konishi and T Ishimitsu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Michiko Yoshii

32 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michiko Yoshii Japan 10 141 137 118 116 108 34 456
P. Tso United States 11 221 1.6× 118 0.9× 64 0.5× 177 1.5× 61 0.6× 18 643
P Pircher United States 7 145 1.0× 264 1.9× 17 0.1× 158 1.4× 90 0.8× 9 471
T. Nakai Japan 13 172 1.2× 34 0.2× 37 0.3× 158 1.4× 54 0.5× 27 560
Masayasu Inoue Japan 12 104 0.7× 51 0.4× 13 0.1× 173 1.5× 58 0.5× 14 509
Chen S. Suen United States 13 265 1.9× 178 1.3× 26 0.2× 345 3.0× 65 0.6× 23 690
Andrew E. Libby United States 11 71 0.5× 37 0.3× 25 0.2× 158 1.4× 139 1.3× 19 454
Madeléne Sandqvist Sweden 8 157 1.1× 245 1.8× 62 0.5× 172 1.5× 262 2.4× 12 783
Hiroki Kumagai Japan 9 77 0.5× 38 0.3× 43 0.4× 251 2.2× 199 1.8× 12 559
Hillevi Larsson Sweden 11 251 1.8× 260 1.9× 253 2.1× 163 1.4× 169 1.6× 13 926
M. Dodson Michael United States 13 293 2.1× 85 0.6× 35 0.3× 212 1.8× 94 0.9× 19 592

Countries citing papers authored by Michiko Yoshii

Since Specialization
Citations

This map shows the geographic impact of Michiko Yoshii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Yoshii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Yoshii more than expected).

Fields of papers citing papers by Michiko Yoshii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiko Yoshii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Yoshii. The network helps show where Michiko Yoshii may publish in the future.

Co-authorship network of co-authors of Michiko Yoshii

This figure shows the co-authorship network connecting the top 25 collaborators of Michiko Yoshii. A scholar is included among the top collaborators of Michiko Yoshii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiko Yoshii. Michiko Yoshii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Umeda, N., Tadashi Nakagawa, Kaori Ishii, et al.. (2025). Unique compound with anti-allergic action: inhibition of Lyn kinase activity by KIRA6. Frontiers in Pharmacology. 16. 1625798–1625798. 1 indexed citations
2.
Ayoub, Ahmed T., et al.. (2024). A unique compound ameliorating endoplasmic reticulum stress and insulin resistance by binding to β tubulin. The FASEB Journal. 38(21). e70150–e70150. 2 indexed citations
3.
Yoshii, Michiko, et al.. (2023). Effects of Simvastatin on RBL-2H3 Cell Degranulation. Biological and Pharmaceutical Bulletin. 46(7). 874–882.
4.
Yoshii, Michiko, Yuhki Yanase, Ralf Jockers, et al.. (2022). Homocysteine causes neuronal leptin resistance and endoplasmic reticulum stress. PLoS ONE. 17(12). e0278965–e0278965. 4 indexed citations
5.
Hosoi, Toru, et al.. (2017). Mechanisms of the action of adenine on anti‐allergic effects in mast cells. Immunity Inflammation and Disease. 6(1). 97–105. 7 indexed citations
6.
Hosoi, Toru, et al.. (2008). Endoplasmic Reticulum Stress Induces Leptin Resistance. Molecular Pharmacology. 74(6). 1610–1619. 171 indexed citations
7.
Yoshii, Michiko, Kazuo Sakiyama, Shinichi Abe, et al.. (2007). Changes in the Myosin Heavy Chain 2a and 2b Isoforms of the Anterior Belly of the Digastric Muscle Before and After Weaning in Mice. Anatomia Histologia Embryologia. 37(2). 147–152. 8 indexed citations
8.
Minami, J., Michiko Yoshii, Toshio Nishikimi, et al.. (2002). Effects of alcohol restriction on ambulatory blood pressure, heart rate, and heart rate variability in Japanese men. American Journal of Hypertension. 15(2). 125–129. 19 indexed citations
9.
Une, Mizuho, et al.. (1997). Bile Acid Profiles in a Peroxisomal D-3-Hydroxyacyl-CoA Dehydratase/D-3-Hydroxyacyl-CoA Dehydrogenase Bifunctional Protein Deficiency. The Journal of Biochemistry. 122(3). 655–658. 20 indexed citations
11.
Shimizu, Hideki, et al.. (1995). Hypocholesterolemic Effect of 5.BETA.-Cholane-3.ALPHA.,7.BETA.,24-triol-24-sulfate in Hamsters.. Biological and Pharmaceutical Bulletin. 18(1). 28–32. 2 indexed citations
12.
Mosbach, Erwin H., et al.. (1995). Synthesis and metabolism of sodium 3α,7α‐dihydroxy‐25,26‐bishomo‐5β‐cholane‐26‐sulfonate in the hamster. Lipids. 30(1). 71–78. 3 indexed citations
13.
Cohen, Bertram I., Erwin H. Mosbach, Richard J. Stenger, et al.. (1993). Bile Acid Sulfonates Alter Cholesterol Gallstone Incidence in Hamsters. Hepatology. 17(1). 103–110. 5 indexed citations
14.
Shimizu, Hideki, et al.. (1992). Hypocholesterolemic Effect of Ursodeoxycholylcysteic Acid in Hamsters Fed a High Cholesterol Diet.. Journal of Pharmacobio-Dynamics. 15(10). 573–580. 3 indexed citations
17.
Cohen, Bertram I., et al.. (1991). Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. Gastroenterology. 101(4). 1109–1116. 26 indexed citations
18.
Kihira, Kenji, et al.. (1991). Metabolism of Sodium 3α,7αlydroxy-5β9-Cholane-24-Sulfonate in Hamsters. The Journal of Biochemistry. 109(6). 879–881. 8 indexed citations
19.
Yoshii, Michiko, et al.. (1990). Identification of 3,6,7,12-tetrahydroxy-5β-cholan-24-oic acids in human biologic fluids. Steroids. 55(11). 512–515. 4 indexed citations
20.
Une, Mizuho, et al.. (1989). Identification of 3α, 6α, 7α, 12α-Tetrahydroxy-5β-Cholestanoic Acid in Zellweger's Syndrome. The Journal of Biochemistry. 106(3). 501–504. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026